Close Menu

A team led by Tokyo Medical University researchers have identified a microRNA that regulates extracellular vesicle (EV) secretion from prostate cancer cells, offering a potential new therapeutic target for the disease. Given the role of aberrant miRNA expression in cancer and the importance of EVs to cancer progression, the scientists screened thousands of miRNAs using ExoScreen, a liquid biopsy technique they previously developed for detecting disease-specific EVs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.